Table 2 Published trials of low-dose vasopressin in human septic shock
From: Clinical review: Vasopressin and terlipressin in septic shock patients
Reference | Study design (n) | Observed effects |
|---|---|---|
[1] | Case series (5) | A, B, C |
[3] | Matched cohort (19) | A, B, D |
[9] | Randomized clinical trial versus placebo (10) | A, B |
[15] | Case series (16) | A, C |
[16] | Case series (50) | A, B, C |
[17] | Retrospective case series (38) | A |
[18] | Randomized clinical trial: noradrenaline + vasopressin versus noradrenaline (48) | A, B, C, E, F |
[19] | Randomized clinical trial: noradrenaline versus vasopressin (24) | B, C, D, F, G |
[99] | Cases series (11) | H |
[100] | Noradrenaline versus vasopressin (12) | A, F, H |